The effect of Curcuma Longa on the chest pain, sleep quality and hemodynamic indices in patients with acute coronary syndrome
Phase 3
Recruiting
- Conditions
- Acute coronary syndrome.
- Registration Number
- IRCT20110427006318N14
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Diagnosis acute coronary syndrome
Patient consent for participation in the study
Patient 45 to 75 years old
Lack of active mental illness, mental retardation, deafness, blindness
Lack of sensitivity to Curcuma Longa
Lack of addiction to alcohol and Opioid
Patients who are able to speak and understand language and conscious
No history of sleeping drugs consumption
Chest pain score greater than four
Systolic blood pressure 90-100 mmHg
Exclusion Criteria
Pregnant women
Patients with gallstones or bile disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chest pain. Timepoint: Evaluation of pain is performed before and half an hour after the intervention for three consecutive days. Method of measurement: Numeric Rating Scale.
- Secondary Outcome Measures
Name Time Method Sleep quality. Timepoint: Evaluation of sleep quality is performed before the intervention and three consecutive days. Method of measurement: St Mary's Hospital Sleep Questionnaires.;Hemodynamic indicators. Timepoint: Evaluation of hemodynamic parameters is performed before and half an hour after the intervention for three consecutive days. Method of measurement: Monitor of Pooyandegan Rah-e-Salamat.